UBS maintains Xometry at Neutral, raises price target to $108 from $95
UBS kept Xometry at Neutral but raised its price target to $108 from $95, a 13.7% increase. This implies a 4.9% downside from the Nov 4 close of $113.52. Recent analyst targets range from $117 to $140.
How this was made

The 30-second read
Why it matters
The latest target of $108 is a modest increase from the prior $95, but still below the current market price of $113.52.
Market read
A new analyst target may influence short‑term sentiment but offers limited trading edge given the price gap.
What to watch
No discussion of underlying business fundamentals or upcoming contracts.
Background
UBS analyst coverage of Xometry includes a series of recent target revisions ranging from $117 to $140.
Ticker impact
UBS raised its price target on Xometry to $108 from $95, a new analyst recommendation.
potential downside as the market prices in the target being below current levels
The target is lower than the current share price, so investors may view the stock as overvalued and could see selling pressure.
Market effects
Minimal impact on the broader manufacturing services sector.
Limited to U.S. investors tracking Xometry.
Low
Counterpoint
The target raise may be a lagging reaction; the stock could still rally if earnings beat expectations.
Key entities
- AnalystUBS
Investment bank providing the new price target.
- CompanyXometry
U.S.-listed manufacturing marketplace.


